These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11169805)

  • 1. Perioperative prediction by MRI of prostate volume six to twelve months after laser-induced thermotherapy of benign prostatic hyperplasia.
    Mueller-Lisse UG; Frimberger M; Schneede P; Heuck AF; Muschter R; Reiser MF
    J Magn Reson Imaging; 2001 Jan; 13(1):64-8. PubMed ID: 11169805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulative interstitial laser-induced thermotherapy of benign prostatic hyperplasia: online imaging with a T2-weighted fast spin-echo MR sequence--experience in six patients.
    Mueller-Lisse UG; Thoma M; Faber S; Heuck AF; Muschter R; Schneede P; Weninger E; Hofstetter AG; Reiser MF
    Radiology; 1999 Feb; 210(2):373-9. PubMed ID: 10207417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MRI monitoring before, during and after interstitial laser-induced hyperthermia of benign prostatic hyperplasia. Initial clinical experiences].
    Müller-Lisse GU; Heuck A; Stehling MK; Frimberger M; Thoma M; Schneede P; Muschter R; Hofstetter A; Reiser M
    Radiologe; 1996 Sep; 36(9):722-31. PubMed ID: 8999449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative MRI in patients undergoing interstitial laser coagulation thermotherapy of benign prostatic hyperplasia.
    Mueller-Lisse UG; Heuck AF; Schneede P; Muschter R; Scheidler J; Hofstetter AG; Reiser MF
    J Comput Assist Tomogr; 1996; 20(2):273-8. PubMed ID: 8606236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictability of the size of laser-induced lesions in T1-Weighted MR images obtained during interstitial laser-induced thermotherapy of benign prostatic hyperplasia.
    Mueller-Lisse UG; Heuck AF; Thoma M; Muschter R; Schneede P; Weninger E; Faber S; Hofstetter A; Reiser MF
    J Magn Reson Imaging; 1998; 8(1):31-9. PubMed ID: 9500258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of non-enhanced MRI to monitor histological lesion size during laser-induced interstitial thermotherapy.
    Bremer C; Kreft G; Filler T; Reimer P
    Eur Radiol; 2002 Jan; 12(1):237-44. PubMed ID: 11868103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.
    Colin P; Nevoux P; Marqa M; Auger F; Leroy X; Villers A; Puech P; Mordon S; Betrouni N
    BJU Int; 2012 Feb; 109(3):452-8. PubMed ID: 21895930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.
    deSouza NM; Flynn RJ; Coutts GA; Gilderdale DJ; Hall AS; Puni R; Chui M; Harris DN; Kiely EA
    AJR Am J Roentgenol; 1995 Jun; 164(6):1429-34. PubMed ID: 7538727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Likelihood of prostate cancer based on prostate-specific antigen density by MRI: retrospective analysis.
    Mueller-Lisse UG; Mueller-Lisse UL; Haller S; Schneede P; Scheidler JE; Schmeller N; Hofstetter AG; Reiser MF
    J Comput Assist Tomogr; 2002; 26(3):432-7. PubMed ID: 12016375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral microwave thermotherapy of the prostate--evaluation with MRI and analysis of parameters relevant to outcome.
    Vesely S; Müller M; Knutson T; Peeker R; Hellström M; Dahlstrand C
    Scand J Urol Nephrol; 2008; 42(1):53-8. PubMed ID: 18210336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between benign prostatic hyperplasia and prostate cancer in the transitional zone evaluated by 1H magnetic resonance spectroscopic imaging.
    Li SY; Chen M; Wang R; Zhou C
    Chin Med Sci J; 2007 Dec; 22(4):238-42. PubMed ID: 18246671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE.
    Lin YT; Amouyal G; Correas JM; Pereira H; Pellerin O; Del Giudice C; Déan C; Thiounn N; Sapoval M
    Eur Radiol; 2016 Oct; 26(10):3466-73. PubMed ID: 26738505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Characteristics of the Transitional Zone in Prostate Growth With Age.
    Cao N; Lu Q; Si J; Wang X; Ni J; Chen L; Gu B; Hu B
    Urology; 2017 Jul; 105():136-140. PubMed ID: 28389262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.
    Garvey B; Türkbey B; Truong H; Bernardo M; Periaswamy S; Choyke PL
    Diagn Interv Radiol; 2014; 20(3):229-33. PubMed ID: 24675166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of MRI T1-based treatment monitoring during laser-induced thermotherapy of liver metastases for necrotic size prediction.
    Wichmann JL; Beeres M; Borchard BM; Naguib NN; Bodelle B; Lee C; Zangos S; Vogl TJ; Mack MG; Eichler K
    Int J Hyperthermia; 2014 Feb; 30(1):19-26. PubMed ID: 24286282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized metric assessment of glandular tissue volume within the peripheral zone of the prostate using combined magnetic resonance imaging and histopathology: Possible pathophysiological implications on prostate cancer development.
    Wolpert JM; Presson C; Kimball N; Lin B; Brandi L; Helo N; de Riese WTW
    Investig Clin Urol; 2024 Jul; 65(4):334-341. PubMed ID: 38978213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.
    Jia G; Heverhagen JT; Henry H; Polzer H; Baudendistel KT; von Tengg-Kobligk H; Levine AL; Rosol TJ; Knopp MV
    Magn Reson Imaging; 2006 Jul; 24(6):721-5. PubMed ID: 16824967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance imaging in the diagnosis of prostatic carcinoma and benign hyperplasia].
    Fujiwara K; Isaka S; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1336-42. PubMed ID: 2480470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prostate size and glandular tissue volume of the peripheral zone via novel combined MRI and histopathology: possible pathophysiological implications on prostate cancer development.
    Lin B; Cavdar IK; Buxton M; Sellers J; Brandi L; Helo N; de Riese WTW
    Int Urol Nephrol; 2023 Apr; 55(4):835-844. PubMed ID: 36739353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.